ArticleBioscience reports2018

Anti-tumor activity of Shikonin against afatinib resistant non-small cell lung cancer via negative regulation of PI3K/Akt signaling pathway.

Baiying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.